Yiling Pharmaceutical: Lianhua Qingwen Approved in Nigeria
SHIJIAZHUANG, China, May 12, 2022 /PRNewswire/ -- Yiling Pharmaceutical disclosed Wednesday that it had received the medicine approval document for Lianhua Qingwen Capsules from the National Agency for Food and Drug Administration and Control (NAFDAC), Nigeria. The Product Category is Herbal and Nutraceuticals. Lianhua Qingwen is one of Yiling's leading products. As a drug included in China's national essential medicines...
Gracell Biotechnologies to Present Clinical Data on BCMA/CD19 Dual-targeting CAR-T GC012F in RRMM and B-NHL and CD19/CD7 Dual-directed Allogeneic CAR-T GC502 in B-ALL at EHA2022 Congress
SAN DIEGO, Calif., SUZHOU and SHANGHAI, China , May 12, 2022 /PRNewswire/ -- Gracell Biotechnologies Inc. ("Gracell" or the "Company", NASDAQ: GRCL), a global clinical-stage biopharmaceutical company dedicated to developing highly efficacious and affordable cell therapies for the treatment of cancer, today announced the details of three abstracts that it will...
BIORCHESTRA Participated in Formulation and Delivery
BOSTON, May 12, 2022 /PRNewswire/ -- BIORCHESTRA is a leading RNA therapeutics company that develops novel RNA-based therapeutics and drug delivery systems for neurodegenerative diseases. BBB penetration in vivo confocal microscopy clip BIORCHESTRA CEO Branden(Jinhyeob) Ryu and Chief Medical Officer, Dr. Louis O'Dea, participated in...
Formosa Pharmaceuticals and AimMax Therapeutics Announce Successful Top-Line Results from CPN-301 for the Treatment of Inflammation and Pain after Cataract Surgery
TAIPEI, May 12, 2022 /PRNewswire/ -- Formosa Pharmaceuticals, Inc. (TWO.6838) and AimMax Therapeutics, Inc. (United States) report successful top-line results from CPN-301, the first of two pivotal Phase 3 clinical studies of APP13007, a novel ophthalmic nanosuspension formulation of a potent corticosteroid, clobetasol propionate(0.05%), for the treatment of inflammation and pain after cataract surgery. Formosa Pharmaceuticals, Inc. & AimMax...
JinkoSolar Donated 500kWp Solar Modules Transported by the CMA CGM Group to the Philippines Red Cross
SHANGHAI, May 12, 2022 /PRNewswire/ -- JinkoSolar, one of the largest and most innovative solar module manufacturers in the world, today announced that JinkoSolar joined hands with CMA CGM, a world leader in shipping and logistics, to donate 500kWp Solar Modules to the Philippines Red Cross for disaster relief of Typhoon Rai. More than 3 million residents have been...
GenScript ProBio Establishes Korean Legal Entity and Further Strengthens Cooperation in South Korea and APAC Region
NANJING, China, May 12, 2022 /PRNewswire/ -- On the May 12, 2022, GenScript ProBio (Brian Ho-sung Min, CEO), a global CDMO company from GenScript Biotech Corporation, today announced the opening of a legal entity in South Korea at the BIO KOREA 2022 International Convention. BIO KOREA 2022 International Convention is the biggest bio-health convention in Asia. Dr.Brian Min, CEO of...
WESMYLE Launches UTC Pro Capsule-Shape Portable Sonic Electric Toothbrush on Kickstarter
Featuring a Capsule-shape design Electric Toothbrush with Built-In UVC-LED Sterilizer for a 100% Bacteria-Free Toothbrush HONG KONG, May 12, 2022 /PRNewswire/ -- UTC Pro, a professional-grade 100% bacteria-proof and rust-proof electric toothbrush that can be seamlessly operated from one single button, has been launched today on Kickstarter, at <https://www.kickstarter.com/projects/1271636145/utc-pro-the-full-function-true-portable-electric-toothbrush?ref=4seqda>. A set of innovative features and functionalities is expected to...
INFOBAE.COM: Houston doctors and researchers that are making the biggest international impact according to the KOLs list – Most of them are women
SANTA BARBARA, Calif., May 12, 2022 /PRNewswire/ -- The work of Houston doctors and researchers is getting international attention. The most researched areas in Houston after COVID are Oncology, Cardiology, and Endocrinology. According to the KOLs list, the leading institutions are The University Of Texas MD Anderson, Houston Methodist, Harris Health System, Heart Institute, and Baylor College Of Medicine. Gender...
Zhimeng Biopharma Announces Dosing of First Subject of Its Novel Antiepileptic Drug Candidate CB03 in First-in-Human Phase I Clinical Trial
SHANGHAI, May 12, 2022 /PRNewswire/ -- Shanghai Zhimeng Biopharma, Inc. ("Zhimeng"), announced dosing of the first participant in the US Phase I study in healthy subjects of its innovative small-molecule KCNQ2/3 selective opener (CB03), developed for the treatment of refractory epilepsy. CB03 is a candidate drug for the treatment of refractory epilepsy, independently developed by Zhimeng. The phase...
VolitionRx Limited Announces First Quarter 2022 Financial Results and Business Update
Conference call to discuss financial and operational results scheduled for Thursday, May 12, at 8:30 a.m. U.S. Eastern Time AUSTIN, Texas, May 12, 2022 /PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition") today announced financial results and a business update for the first quarter ended March 31, 2022. Volition management will host a conference call tomorrow, May 12 at...
